
Sign up to save your podcasts
Or


This episode charts the century-long history of prolactin research, tracing how scientists mapped its complex neuroendocrine regulation. We begin with the discovery of its lactogenic properties in 1928 and the paradigm-shifting realization that the hypothalamus exerts tonic inhibition over its release via tuberoinfundibular dopamine neurons. The discussion covers the identification of stimulatory factors like thyrotropin-releasing hormone, estrogen, and oxytocin, the molecular characterization of short-loop negative feedback, and its modern reemergence as a vital metabolic regulator.
This episode examines why the body maintains two distinct neuroendocrine centers in the brain. The hypothalamus acts as a neural-to-endocrine transducer, converting complex electrical inputs from the brain into a chemical language. Using a private hypophyseal portal vascular system, it delivers releasing hormones directly to the nearby anterior pituitary. Rather than a redundant relay, the pituitary provides massive signal amplification, integrates multi-hormonal inputs, and decodes pulsatile signals to manage peripheral organs.
This episode explores how the body processes thyroxine to customize thyroid hormone action at the cellular level. We examine how the single circulating pool of prohormone follows one of two peripheral pathways to arrive at its final destination, diiodothyronine. By choosing whether outer-ring activation or inner-ring inactivation occurs first, type one, type two, and type three iodothyronine deiodinases grant individual tissues autonomous, tissue-specific metabolic control without disturbing systemic concentrations.
Obstructive sleep apnea represents a critical yet frequently underdiagnosed secondary driver of metabolic dysfunction and endocrine pathology. This episode explores the complex bidirectional relationship between nocturnal hypoxia and endocrine systems, detailing how sleep fragmentation disrupts the hypothalamic-pituitary-adrenal axis, elevates cortisol levels, and induces severe insulin resistance.
The insulin tolerance test remains the gold standard for evaluating suspected growth hormone deficiency and secondary adrenal insufficiency. By administering intravenous insulin to deliberately induce hypoglycemia, clinicians can provoke and assess the hypothalamic-pituitary-adrenal axis response. This episode breaks down the physiological mechanisms behind the test, outlines strict patient safety protocols, and discusses how to interpret cortisol and growth hormone nadirs to establish an accurate clinical diagnosis in complex endocrine cases.
This episode examines the evolving landscape of kidney function assessment in endocrine care, focusing on the limitations of traditional creatinine and the clinical utility of cystatin C. We explore how modern estimating equations have eliminated race to improve diagnostic equity, and analyze how common therapies like SGLT2 inhibitors impact renal metrics without causing true injury. Listeners will learn why combining multiple biomarkers provides the most reliable strategy for monitoring renal health and predicting long term patient outcomes.
In this episode, we dive into the Women's Health Initiative, the landmark clinical research effort that fundamentally reshaped postmenopausal healthcare. We break down the complex realities of hormone replacement therapy, contrasting the risks of combined therapy against the surprising benefits of estrogen-alone regimens. Listeners will explore the timing hypothesis, learning how starting hormones early in menopause changes the safety profile entirely, alongside critical insights regarding dietary modifications, calcium supplementation, and individualized patient care.
This episode of Endocrine Deep Dives reviews struma ovarii, a rare ovarian teratoma dominated by functional thyroid tissue. We examine how this ectopic tissue causes thyrotoxicosis with low cervical radioiodine uptake, mimicking thyroiditis or factitious ingestion. The discussion highlights diagnostic strategies using pelvic imaging and whole-body radioiodine scans. Finally, we explore risk-stratified management, addressing when to pursue conservative ovarian resection versus total thyroidectomy, radioactive iodine therapy, and long-term thyroglobulin surveillance.
This episode of Endocrine Deep Dives explores the diagnostic nuances of the adrenocorticotropic hormone stimulation test. We break down how this core dynamic assay differentiates primary adrenal insufficiency from secondary adrenal insufficiency by evaluating cortisol reserve. The discussion covers standard two hundred fifty microgram protocols, limitations in early pituitary disease, and the clinical utility of baseline morning cortisol and dehydroepiandrosterone sulfate. Finally, we analyze critical updates to assay-specific diagnostic cutoffs required by modern monoclonal testing platforms.
This episode delivers a rigorous evaluation of hemoglobin A1c pitfalls where the marker fails to accurately reflect true glycemia. We examine how altered erythrocyte turnover, hemoglobin variants, and specific clinical conditions distort glycation dynamics independently of plasma glucose levels. Listeners will learn to identify when to suspect inaccurate A1c readings, how conditions like advanced chronic kidney disease or hemoglobinopathies confound data, and when to utilize alternative biomarkers like fructosamine or continuous glucose monitoring metrics instead.
From the publisher's feed